About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Leukemia Clinical Trials | 379 Studies Recruiting

Clinical TrialsLeukemia

Leukemia Clinical Trials

Browse 379 clinical trials for leukemia. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 141-160 of 379 trials

CompletedVNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic SyndromeRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00049686·Houston, Texas CompletedCombination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic CancerRATIONALE: Giving chemotherapy before a donor bone marrow transplant helps stop the growth of cancer and abnormal cells and helps stop the patient's immune system from rejecting…NCT00134017·Baltimore, Maryland CompletedMycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerRATIONALE: Monoclonal antibodies such as daclizumab can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells.NCT00006350·Baltimore, Maryland

Related Searches

amltrials cmltrials alltrials clltrials

Data from ClinicalTrials.govTerms

RecruitingMyeloablative Allo HSCT With Related or Unrelated Donor for Heme DisordersThis is a Phase II study of allogeneic hematopoietic stem cell transplant (HCT) using a myeloablative preparative regimen (of either total body irradiation (TBI); or…NCT03314974·Minneapolis, Minnesota

CompletedMotexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00036790·Pittsburgh, Pennsylvania and 1 other

WithdrawnMulti-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell TransplantThis randomized phase II trial studies how well multi-antigen cytomegalovirus (CMV)-modified vaccinia Ankara vaccine works in reducing CMV related complications in patients with…NCT03438344·Duarte, California and 2 others

CompletedPS-341 in Treating Patients With Hematologic CancerRATIONALE: PS-341 may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth.NCT00006098·New York, New York

CompletedHigh-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid TumorsRATIONALE: Radiation therapy uses high-energy x-rays to damage cancer cells.NCT00060255·Buffalo, New York

CompletedStem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood CancerThis study will investigate the safety and effectiveness of a new stem cell transplant procedure to treat acute or chronic leukemia, multiple myeloma, myelodysplastic syndrome…NCT00005785·Bethesda, Maryland

TerminatedHaploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cellsPatients with hematologic malignancies will receive myeloablative chemotherapy followed by stem cell rescue with bone marrow or hematopoietic peripheral blood stem cells collected…NCT01050764·Stanford, California

TerminatedStudy Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological MalignancyThis is an open-label, single arm phase 1 study to evaluate the dose-limiting toxicity, maximum tolerated dose, and recommended phase II dose of Clioquinol in patients with…NCT00963495·Toronto, Ontario

CompletedTacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic CancerThis phase II trial studies how well tacrolimus and mycophenolate mofetil works in preventing graft-versus-host disease in patients who have undergone total-body irradiation (TBI)…NCT00089011·Salt Lake City, Utah and 4 others

TerminatedUmbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological DiseasesThis is a treatment guideline for an unrelated umbilical cord blood transplant (UCBT) using a myeloablative preparative regimen for the treatment of hematological diseases…NCT01962636·Minneapolis, Minnesota

CompletedTotal-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic CancersRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells.NCT00003572·Baltimore, Maryland

CompletedInducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell TransplantationThis is a phase I single center dose escalation study with an extension at the best available dose to determine the tolerability of inducible regulatory T cells (iTregs) when…NCT01634217·Minneapolis, Minnesota

CompletedMethotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell TransplantRATIONALE: Methotrexate and glucocorticoid therapy, such as prednisone or methylprednisolone, may be an effective treatment for acute graft-versus-host disease caused by a donor…NCT00357084·Seattle, Washington

CompletedMethods to Enhance the Safety and Effectiveness of Stem Cell TransplantsBone marrow stem cell transplants (otherwise called bone marrow transplants) from healthy donors are sometimes the only means of curing hematological malignant diseases such as…NCT00378534·Bethesda, Maryland

CompletedAprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell TransplantRATIONALE: Antiemetic drugs, such as aprepitant, ondansetron, and dexamethasone, may help lessen or prevent nausea and vomiting in patients undergoing a stem cell transplant.NCT00248547·Portland, Oregon

CompletedCyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological MalignanciesThis phase II trial studies how well cyclophosphamide works in preventing chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplant in patients with…NCT01427881·Seattle, Washington

CompletedDonor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseRATIONALE: Giving chemotherapy before a donor stem cell transplant helps stop the growth of cancer or abnormal cells.NCT00521430·Seoul

PreviousPage 8 of 19Next